These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 26712589)
1. Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations. Mirabile A; Airoldi M; Ripamonti C; Bolner A; Murphy B; Russi E; Numico G; Licitra L; Bossi P Crit Rev Oncol Hematol; 2016 Mar; 99():100-6. PubMed ID: 26712589 [TBL] [Abstract][Full Text] [Related]
2. Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements. De Sanctis V; Bossi P; Sanguineti G; Trippa F; Ferrari D; Bacigalupo A; Ripamonti CI; Buglione M; Pergolizzi S; Langendjik JA; Murphy B; Raber-Durlacher J; Russi EG; Lalla RV Crit Rev Oncol Hematol; 2016 Apr; 100():147-66. PubMed ID: 26947812 [TBL] [Abstract][Full Text] [Related]
3. Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus. Mirabile A; Numico G; Russi EG; Bossi P; Crippa F; Bacigalupo A; De Sanctis V; Musso S; Merlotti A; Ghi MG; Merlano MC; Licitra L; Moretto F; Denaro N; Caspiani O; Buglione M; Pergolizzi S; Cascio A; Bernier J; Raber-Durlacher J; Vermorken JB; Murphy B; Ranieri MV; Dellinger RP Crit Rev Oncol Hematol; 2015 Aug; 95(2):191-213. PubMed ID: 25818202 [TBL] [Abstract][Full Text] [Related]
4. Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus. Russi EG; Moretto F; Rampino M; Benasso M; Bacigalupo A; De Sanctis V; Numico G; Bossi P; Buglione M; Lombardo A; Airoldi M; Merlano MC; Licitra L; Denaro N; Pergolizzi S; Pinto C; Bensadoun RJ; Girolomoni G; Langendijk JA Crit Rev Oncol Hematol; 2015 Oct; 96(1):167-82. PubMed ID: 26187236 [TBL] [Abstract][Full Text] [Related]
5. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement. Buglione M; Cavagnini R; Di Rosario F; Maddalo M; Vassalli L; Grisanti S; Salgarello S; Orlandi E; Bossi P; Majorana A; Gastaldi G; Berruti A; Trippa F; Nicolai P; Barasch A; Russi EG; Raber-Durlacher J; Murphy B; Magrini SM Crit Rev Oncol Hematol; 2016 Jun; 102():47-54. PubMed ID: 27061883 [TBL] [Abstract][Full Text] [Related]
6. Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus. Schindler A; Denaro N; Russi EG; Pizzorni N; Bossi P; Merlotti A; Spadola Bissetti M; Numico G; Gava A; Orlandi E; Caspiani O; Buglione M; Alterio D; Bacigalupo A; De Sanctis V; Pavanato G; Ripamonti C; Merlano MC; Licitra L; Sanguineti G; Langendijk JA; Murphy B Crit Rev Oncol Hematol; 2015 Nov; 96(2):372-84. PubMed ID: 26141260 [TBL] [Abstract][Full Text] [Related]
7. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement. Buglione M; Cavagnini R; Di Rosario F; Sottocornola L; Maddalo M; Vassalli L; Grisanti S; Salgarello S; Orlandi E; Paganelli C; Majorana A; Gastaldi G; Bossi P; Berruti A; Pavanato G; Nicolai P; Maroldi R; Barasch A; Russi EG; Raber-Durlacher J; Murphy B; Magrini SM Crit Rev Oncol Hematol; 2016 Jan; 97():131-42. PubMed ID: 26318095 [TBL] [Abstract][Full Text] [Related]
8. Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data. Blakaj A; Bonomi M; Gamez ME; Blakaj DM Oral Oncol; 2019 Aug; 95():29-34. PubMed ID: 31345391 [TBL] [Abstract][Full Text] [Related]
9. SAMITAL® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind Phase II study. Pawar D; Neve RS; Kalgane S; Riva A; Bombardelli E; Ronchi M; Petrangolini G; Morazzoni P Support Care Cancer; 2013 Mar; 21(3):827-34. PubMed ID: 22945882 [TBL] [Abstract][Full Text] [Related]
10. Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis. Chaitanya B; Pai KM; Yathiraj PH; Fernandes D; Chhaparwal Y Oral Oncol; 2017 Sep; 72():179-182. PubMed ID: 28797456 [TBL] [Abstract][Full Text] [Related]
11. Systematic review of basic oral care for the management of oral mucositis in cancer patients. McGuire DB; Fulton JS; Park J; Brown CG; Correa ME; Eilers J; Elad S; Gibson F; Oberle-Edwards LK; Bowen J; Lalla RV; Support Care Cancer; 2013 Nov; 21(11):3165-77. PubMed ID: 24018908 [TBL] [Abstract][Full Text] [Related]
12. Cancer treatment-induced oral mucositis: a critical review. Rodríguez-Caballero A; Torres-Lagares D; Robles-García M; Pachón-Ibáñez J; González-Padilla D; Gutiérrez-Pérez JL Int J Oral Maxillofac Surg; 2012 Feb; 41(2):225-38. PubMed ID: 22071451 [TBL] [Abstract][Full Text] [Related]
13. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer. Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862 [TBL] [Abstract][Full Text] [Related]
14. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer. Franco P; Martini S; Di Muzio J; Cavallin C; Arcadipane F; Rampino M; Ostellino O; Pecorari G; Garzino Demo P; Fasolis M; Airoldi M; Ricardi U Med Oncol; 2017 May; 34(5):81. PubMed ID: 28386836 [TBL] [Abstract][Full Text] [Related]
15. Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature. Moslemi D; Nokhandani AM; Otaghsaraei MT; Moghadamnia Y; Kazemi S; Moghadamnia AA Radiother Oncol; 2016 Jul; 120(1):13-20. PubMed ID: 27113797 [TBL] [Abstract][Full Text] [Related]
16. [The timing of the appearance of oral mucositis induced by concurrent chemoradiotherapy with S-1 for head and neck cancer]. Yonekita H; Takase H; Ogata K; Futagami K; Nomoto S; Yoshimitsu K; Nakagawa T; Tokunaga S Gan To Kagaku Ryoho; 2014 Dec; 41(13):2571-5. PubMed ID: 25596050 [TBL] [Abstract][Full Text] [Related]
17. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer. Chung YL; Pui NNM Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040 [TBL] [Abstract][Full Text] [Related]
18. Spectrum of fungal infection in head and neck cancer patients on chemoradiotherapy. Singh GK; Capoor MR; Nair D; Bhowmik KT J Egypt Natl Canc Inst; 2017 Mar; 29(1):33-37. PubMed ID: 28258917 [TBL] [Abstract][Full Text] [Related]
19. World Workshop on Oral Medicine VII: Non-opioid pain management of head and neck chemo/radiation-induced mucositis: A systematic review. Christoforou J; Karasneh J; Manfredi M; Dave B; Walker JS; Dios PD; Epstein J; Kumar N; Glick M; Lockhart PB; Patton LL Oral Dis; 2019 Jun; 25 Suppl 1():182-192. PubMed ID: 30811811 [TBL] [Abstract][Full Text] [Related]
20. Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer. Bossi P; Locati L; Bergamini C; Mirabile A; Granata R; Imbimbo M; Resteghini C; Licitra L Oral Oncol; 2014 Sep; 50(9):884-7. PubMed ID: 25001894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]